INSM - Insmed Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.47B
Enterprise Value 31.27B
Trailing P/E N/A
Forward P/E 1-7.78
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)23.85
Price/Book (mrq)4.13
Enterprise Value/Revenue 320.64
Enterprise Value/EBITDA 6-4.26

Trading Information

Stock Price History

Beta (3Y Monthly) 3.44
52-Week Change 3-22.83%
S&P500 52-Week Change 31.35%
52 Week High 333.13
52 Week Low 311.31
50-Day Moving Average 320.47
200-Day Moving Average 326.07

Share Statistics

Avg Vol (3 month) 31.31M
Avg Vol (10 day) 31.13M
Shares Outstanding 577.67M
Float 80.56M
% Held by Insiders 11.16%
% Held by Institutions 1107.69%
Shares Short (Jul 31, 2019) 411.53M
Short Ratio (Jul 31, 2019) 411.11
Short % of Float (Jul 31, 2019) 425.78%
Short % of Shares Outstanding (Jul 31, 2019) 412.93%
Shares Short (prior month Jun 28, 2019) 412.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Mar 3, 2011

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-491.63%

Management Effectiveness

Return on Assets (ttm)-24.83%
Return on Equity (ttm)-88.00%

Income Statement

Revenue (ttm)61.71M
Revenue Per Share (ttm)0.79
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-78.99M
EBITDA -299.15M
Net Income Avi to Common (ttm)-319.98M
Diluted EPS (ttm)-4.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)601.26M
Total Cash Per Share (mrq)6.74
Total Debt (mrq)368.84M
Total Debt/Equity (mrq)103.44
Current Ratio (mrq)7.54
Book Value Per Share (mrq)4.00

Cash Flow Statement

Operating Cash Flow (ttm)-289.53M
Levered Free Cash Flow (ttm)-175.51M